AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Jubi-R Injection

Prescription Icon
Prescription Required

Marketer

Jubilant Generics Limited

Salt Composition

Remdesivir (100mg)

Overview Jubi-R Injection

Ronacept injection combats a wide range of viruses. Hospitalized adults and children with severe, confirmed or suspected COVID-19 may receive it. This treatment reduces viral levels and accelerates recovery by blocking RNA polymerase, a crucial enzyme for SARS-CoV-2 replication. Administered intravenously under medical supervision, Ronacept should only be used as prescribed. Dosage and treatment duration must strictly follow physician instructions; self-administration is prohibited. Common side effects include elevated blood sugar, anemia, kidney impairment, elevated liver enzymes, and fever. Report any adverse reactions or concerning side effects to your physician immediately. Inform your doctor if you are pregnant, breastfeeding, or elderly/a child, as caution is advised in these groups.

Primary Ingredients of Jubi-R Injection

No text provided. Please provide the text you want me to rephrase.

Uses of Jubi-R Injection

Managing Coronavirus Infection (COVID-19)

Major Benefits of Jubi-R Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Jubi-R Injection:

  • Headache
  • Rash
  • Extravasation
  • Increased prothrombin time
  • Increased transaminase level in blood

How to use Jubi-R Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Jubi-R Injection works:

Jubi-R Injection is a wide-ranging antiviral medication. Its mechanism of action involves suppressing RNA polymerase, an RNA-dependent enzyme crucial for SARS-CoV-2 replication. This inhibition reduces the viral burden within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Jubi-R Injection may be unsafe; physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jubi-R Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Jubi-R Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Jubi-R Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Jubi-R Injection's use in individuals with renal impairment. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Jubi-R Injection's use in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Jubi-R Injection :

NA

Facts to Know About Jubi-R Injection

LabelValue
Chemical Category Amino acid alkyl esters
Developing Habits No.
Type of Therapy Antimicrobials

FAQs on Jubi-R Injection

COVID-19, caused by the novel SARS-CoV-2 virus, is a highly contagious respiratory illness. This newly emerged virus primarily affects the lungs, causing symptoms such as fever, cough, and shortness of breath.
Jubi-R Injection, an antiviral medication, demonstrated effectiveness in managing hospitalized patients with severe COVID-19 in recent laboratory studies. While not yet approved for COVID-19 treatment, these studies suggest faster recovery in patients receiving Jubi-R Injection compared to other treatments. However, its safety and efficacy in treating COVID-19 require further investigation, and numerous clinical trials are underway.
The Food and Drug Administration (FDA), under the Food, Drug, and Cosmetic Act, issues Emergency Use Authorizations (EUAs) for medical products—including medicines, vaccines, and diagnostic devices—to combat serious public health threats like COVID-19. An EUA allows the use of these products before full approval, balancing potential benefits against known risks.
Jubi-R Injection is administered intravenously by a physician only to hospitalized children and adults with severe COVID-19. Severe COVID-19 is defined as SpO2 ≤94% on room air or the need for supplemental oxygen, mechanical ventilation, or ECMO. Self-administration is strictly prohibited. Always follow your doctor's instructions for optimal results.
The EU has authorized Jubi-R Injection for hospitalized patients with severe COVID-19, demonstrating faster recovery from severe respiratory distress in both adult and pediatric populations.
Ongoing clinical trials are evaluating Jubi-R Injection. Preliminary findings indicate it inhibits SARS-CoV-2 replication, reducing viral load and potentially accelerating recovery from COVID-19.
Jubi-R Injection may cause anemia, fever, kidney damage, nausea, vomiting, chills, sweating, low blood pressure, and elevated liver enzymes. However, this list is not exhaustive, and further side effects are possible. Research into Jubi-R Injection and its COVID-19 treatment application is ongoing; therefore, additional risks may exist.
Insufficient data exists to confirm the safety and efficacy of Jubi-R Injection for treating hospitalized adults and children with severe COVID-19. Its use in these patients is permitted only after careful risk-benefit assessment. Ongoing clinical trials are evaluating its safety.
Limited data exists on Jubi-R Injection's use in treating COVID-19. Its safety and effectiveness in pregnant or breastfeeding individuals are unknown. If you are pregnant, breastfeeding, or planning pregnancy, and test positive for, or suspect COVID-19, consult your doctor. They will determine the appropriate course of treatment.
Inform your doctor of all medical conditions, including kidney or liver problems, serious illnesses like heart disease or diabetes, and allergies, before receiving Jubi-R Injection. Disclose all medications—prescription, over-the-counter, vitamins, or herbal products—as Jubi-R Injection may interact with them. Specifically mention use of chloroquine phosphate or hydroxychloroquine sulfate. Also, tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Jubi-R Injection is not a preventative treatment for COVID-19; its efficacy in preventing COVID-19 is unsupported by data.
The Drug Controller General of India (DCGI) has granted emergency use authorization for Jubi-R Injection during the pandemic. Its use is restricted to confirmed COVID-19 patients and only when clinically necessary; it is not approved for preventative purposes or suspected cases.
Jubi-R Injection
2,791
MRP 3,400
17% off